3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mouth Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Leukemia, Myeloid, Acute
1
Fanconi Anemia
1
Erythroplasia
1
COVID-19
1
Interventions
Cyclophosphamide
15
Antilymphocyte Serum
11
fludarabine phosphate
10
Cyclosporine
9
Busulfan
9
Peripheral Blood Stem Cell Transplantation
8
Mycophenolic Acid
7
Filgrastim
7
Methotrexate
6
Whole-Body Irradiation
5
Melphalan
5
fludarabine
4
Radiotherapy
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
Tacrolimus
3
Psychiatric Rehabilitation
3
Palliative Care
3
Blood Specimen Collection
3
sargramostim
2
Thiotepa
2
Therapeutics
2
Stem Cell Transplantation
2
Polymerase Chain Reaction
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Behavior Therapy
2
Ascorbic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myelodysplastic Syndromes
×
Molecular Diagnostic Techniques
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled